Wei Hong
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
-
- Air Quality and Health Impacts 5
-
- RNA modifications and cancer 6
-
- Pulmonary Hypertension Research and Treatments 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Nitric Oxide and Endothelin Effects 4
-
- Vibrio bacteria research studies 3
-
- Biosensors and Analytical Detection 3
- Co-authors
- Pixin RanBing LiYumin ZhouChunxiao LiangGongyong PengPallavi ChaturvediGregg L. SemenzaAndre Levchenko
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wei Hong
37 papers receiving 811 citations
Peers
Comparison fields: 5 of 101
- Cancer Research 235
- Health, Toxicology and Mutagenesis 107
- Molecular Biology 393
- Pulmonary and Respiratory Medicine 158
- Genetics 50
Countries citing papers authored by Wei Hong
This map shows the geographic impact of Wei Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Hong more than expected).
Fields of papers citing papers by Wei Hong
This network shows the impact of papers produced by Wei Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Hong. The network helps show where Wei Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 15 | |
| 8 | 2023 | 30 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 19 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 31 | |
| 15 | 2021 | 5 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 7 | |
| 18 | 2021 | 52 | |
| 19 | 2020 | 42 | |
| 20 | 2019 | 37 |
About Wei Hong
Wei Hong is a scholar working on Endocrinology, Cancer Research and Health, Toxicology and Mutagenesis, having authored 43 papers that have together received 815 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (6 papers), Air Quality and Health Impacts (5 papers), Pulmonary Hypertension Research and Treatments (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Vibrio bacteria research studies (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Biosensors and Analytical Detection (3 papers). The work is most often cited by research in Cancer Research (235 citations), Health, Toxicology and Mutagenesis (107 citations) and Molecular Biology (393 citations). Wei Hong has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Pixin Ran, Bing Li, Yumin Zhou, Chunxiao Liang, Gongyong Peng, Pallavi Chaturvedi, Gregg L. Semenza, Andre Levchenko, Carmen Chak‐Lui Wong and Weibo Luo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.